References
- Hawkey CJ. Non steroidal anti-inflammatory drugs and peptic ulcers. Br Med J 1990;300:278–84.
- Langman MJS, Weil J, Wainwright P, Lawson DH, Rawlins MD, Logan RFA, et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994;343:1075–82.
- Taha AS, Russell RI. Helicobacter pylori and NSAID: uncomfortable partners in peptic ulcer disease. Gut 1993;34:580–3.
- Somerville K, Faulkner G, Langman M. NSAID and bleeding peptic ulcer. Lancet 1986;1:462–4.
- Beard K, Walker AM, Perera DR, Jick H. NSAID and hospitalization for gastroesophageal bleeding in the elderly. Arch Intern Med 1987;147:1621–3.
- LaPorte JR, Carne X, Vidal X, Moreno V, Juan J. Upper gastrointestinal bleeding in relation to previous use of analgesics and NSAID. Lancet 1991;337:85–9.
- Hosking SW, Yung MY, Chung SC, Li AKC. Differing prevalence of Helicobacter pylori in bleeding and nonbleeding ulcers. Gastroenterology 1992;102 Suppl:A85.
- Jensen DM, You S, Pelayo E, Jensen ME. The prevalence of Helicobacter pylori and NSAID use in patients with severe UGI hemorrhage and their potential role in recurrence of ulcer bleeding. Gastroenterology 1992;102 Suppl:A90.
- Jaspersen D. Helicobacter pylori eradication: the best long-term prophylaxis for ulcer bleeding recurrence? Endoscopy 1995;27: 622–5.
- Al-Assi MT, Genta RM, Karttunen TJ, Graham DY. Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use. Endoscopy 1996;28:229–33.
- Pilotto A, Leandro G, Mario FD, Fanceschi M, Bozzola L, Valerio G. Role of Helicobacter pylori infection on upper gastrointestinal bleeding in the elderly. Dig Dis Sci 1997; 42:586–91.
- Cullen DJE, Hawkey GM, Greenwood DC, Humphreys H, Shepherd U, Logan RF, et al. Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs. Gut 1997;41:459–62.
- Loeb DS, Talley NJ, Ahlquist DA, Carpenter HA, Zinsmeister AR. Long-term NSAID use and gastroduodenal injury: the role of Helicobacter pylori. Gastroenterology 1992;102:1899–905.
- Graham DY, Lidsky MD, Cox AM, Evans DJ, Evans DG, Alpert L. Long-term NSAID use and Helicobacter pylori infection. Gastroenterology 1991;100:1653–7.
- Laine L, Marin-Sorensen M, Weistein WM. NSAID-associated gastric ulcers do not require Helicobacter pylori for their development. Am J Gastroenterol 1992;87:1398–402.
- NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65–9.
- Vaira D, Menegatti M, Giglioli M. What is the role of Helicobacter pylori in complicated ulcer disease? Gastroenterology 1997;113:S78–84.
- Graham DY, Hepps KS, Ramirez FC, Lew GM, Saeed ZA. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol 1993;28:939–42.
- Hepps KS, Ramirez FC, Lew GM. Treatment of Helicobacter pylori reduces the rate of rebleeding in complicated peptic ulcer disease. Gastrointest Endosc 1992;38:A234.
- Ng TM, Fock DM, Khor JL, Chia SC, Teo EK, Chong YY. Helicobacter pylori and NSAID in bleeding gastric ulcer. Gastroenterology 1996;110 Suppl:A211.
- Avunduk C, Suliman M, Gang G, Polakowski N, Eastwood GL. Gastroduodenal mucosal prostaglandin generation in patients with H pylori before and after treatment with bismuth subsalicylate. Dig Dis Sci 1991;36:431–4.
- Hudson N, Balsitis M, Filipowicz F, Hawkey CJ. Effect of H pylori colonization on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs. Gut 1993;34:748–51.